Abstract:BACKGROUND:The pathogenesis of severe hepatitis B remains unknown. Reports have indicated that hepatitis B virus (HBV) mutations are important factors in the pathogenesis of this disease. This study was to investigate the genetic heterogeneity of HBV strains from serum samples of patients with fulminant hepatitis B.METHODS:Full-length HBV genomes from 4 patients with severe hepatitis B were cloned and sequenced to observe mutations in every open reading-frame (ORF). Serum samples of another 25 patients with severe hepatitis B, 30 patients with chronic hepatitis B, and 25 HBV carriers were collected for sequencing and comparison of mutations in preS2, preC and core promoter regions.RESULTS:Of 4 HBV full-length genome sequences, 3 had a G to A mutation at nucleotide A1896 in the preC region and 1 had double mutations of T1762-A1764 in the core promoter region. The 4 sequences showed mutations in the known B or T cell epitopes of the preS2 and C regions. For the other 3 groups, more mutations were seen in the preS2 region in the HBV isolates from the patients with severe hepatitis B than those from the patients with chronic hepatitis B and HBV carriers (P<0.01). There was a significant difference of mutations in the T cell epitope region of preS2 between the patients with severe hepatitis B and those with chronic hepatitis B or HBV carriers (P<0.01). In the preC and core promoter regions, the mutation frequencies of T1653 and C1753 were 48.0% and 24.0% respectively in the patients with severe hepatitis B, but none of these mutations were observed in the patients with chronic hepatitis B group or HBV carriers (P<0.01). The mutation frequency of T1762-A1764 was 76.0% in the patients with severe hepatitis B, 40.0% in the patients with chronic hepatitis B (P<0.01), and 16.0% in the HBV carriers (P<0.01). There was a significant difference in A1896 mutation between the patients with severe hepatitis B and the patients with chronic hepatitis B (P<0.05) or the HBV carriers (P<0.05).CONCLUSION:Our observations suggest that the accumulation and persistence of high frequency mutations or complex mutations may be associated with the development and deterioration of HBV infection.

Prevalence And Significance Of Hepatitis B Reverse Transcriptase Mutants In Different Disease Stages Of Untreated Patients

Accumulation of mutations in reverse transcriptase of hepatitis B virus is associated with liver disease severity in treatment-naïve Chinese patients with chronic hepatitis B.

Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients.

Pre-Existing Mutations in Reverse Transcriptase of Hepatitis B Virus in Treatment-Naive Chinese Patients with Chronic Hepatitis B

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Pre-core/basal-core Promoter and Reverse Transcriptase Mutations in Chronic HBV Infected-Patients.

Mutations in Precore and Core Promoter Region of HBV in Patients with Hepatic Failure.

Hepatitis B Virus Mutations Associated with in Situ Expression of Hepatitis B Core Antigen, Viral Load and Prognosis in Chronic Hepatitis B Patients

Novel Natural Mutations in the Hepatitis B Virus Reverse Transcriptase Domain Associated with Hepatocellular Carcinoma.

Prevalence of rt229 polymerase mutations of hepatitis B virus and its influence on the viral replication

Mutation in the RT Region of Hepatitis B Virus and Its Relationship with HBV Genotypes Distribution

The characterization and clinical significance of quasispecies in the reverse transcriptase region of hepatitis B virus in hepatitis B virus infected patients with different disease stages

Profile of Hbv Antiviral Resistance Mutations with Distinct Evolutionary Pathways Against Nucleoside/Nucleotide Analogue Treatment among Chinese Chronic Hepatitis B Patients

Discrepancy of Potential Antiviral Resistance Mutation Profiles Within the HBV Reverse Transcriptase Between Nucleos(t)ide Analogue‐untreated and ‐treated Patients with Chronic Hepatitis B in a Hospital in China

Association Between The Various Mutations In Viral Core Promoter Region To Different Stages Of Hepatitis B, Ranging Of Asymptomatic Carrier State To Hepatocellular Carcinoma

Potential resistant mutations within HBV reverse transcriptase sequences in nucleos(t)ide analogues-experienced patients with hepatitis B virus infection

Investigation of hepatitis B virus (HBV) rtS78T/sC69* mutation in a large cohort of chronic HBV-infected patients with nucleoside/nucleotide analogue treatment.

Hepatitis B virus mutation pattern rtA181S+T184I+M204I may contribute to multidrug resistance in clinical practice: Analysis of a large cohort of Chinese patients

Age And E Antigen Status Are Associated With Pre-Existing Tolerance Mutations In Chinese Patients With Chronic Hbv Infection: A Retrospective Case Control Study

Hepatitis B Virus Pres/s Gene Mutations and Their Clinical Implications

Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients.